Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trialMarkus P. Schlaich, Thomas Guldager Lauridsen, Roland F. Dreier et al.|The Lancet|2022Cited by 223
Mesenchymal stem cells-derived extracellular vesicles-shuttled microRNA-223-3p suppress lipopolysaccharide-induced cardiac inflammation, pyroptosis, and dysfunctionLihua Pan, Lu Qi, Boyu Yan et al.|International Immunopharmacology|2022Cited by 32
Ultra-Small Iron-Based Nanoparticles with Mild Photothermal-Enhanced Cascade Enzyme-Mimic Reactions for Tumor TherapyJing Yu, Shenglei Che|Materials|2025Cited by 2